The Year in Cardiovascular Medicine 2020: Coronary Intervention
The year in cardiovascular medicine 2020: interventional cardiology
Original Research | By KH Chau , AJ Kirtane , RM Easterwood et al.
Transcatheter Interventions for Tricuspid Valve Disease: What to Do and Who to Do it On
Review Article | By G Muntané-Carol, A Alperi, J Rodés-Cabau et al.
Long-term effects of intensive glucose lowering on cardiovascular outcomes
Clinical Trial | By ACCORD Study Group, HC Gerstein, ME Miller et al.
Original Research | By J Schroder, MM Michelsen, ND Mygind et al.
Patient-tailored antithrombotic therapy following percutaneous coronary intervention
Review Article | By NMR van der Sangen, R Rozemeijer, DRPP CP Yin et al.
Review Article | By M Biswas, SK Kali.
PURPOSE - It was aimed to determine the aggregated risk of MACE (major adverse cardiovascular events) in stable CAD patients carrying CYP2C19 LoF alleles taking clopidogrel. METHODS - Literature was searched in different databases for relevant studies. Aggregated risk was estimated using a fixed/random effect model where p-value<0.05 was considered statistically significant. RESULTS...
Clinical Trial | By H Kawashima , K Takahashi , the SYNTAX Extended Survival Investigators et al.
BACKGROUND - The long-term clinical benefit after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in patients with total occlusions (TOs) and complex coronary artery disease has not yet been clarified. OBJECTIVES - The objective of this analysis was to assess 10-year all-cause mortality in patients with TOs undergoing PCI or CABG. M...